Q: On Saturday there was a press release regarding the results of a heart drug study and the share price of the company has bombed today. The results noted appeared positive to me however I am not an expert on the drug study details. Do you know why there is such a drastic adverse reaction to the Amarin stock price?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Could you please give me your view on these two companies, and what their growth prospects look like at current prices? Which would you find more compelling in the animal health sector?
Q: Hello 5i Team,
Judging how emotional this market is, would you suggest in waiting for Savaria's earnings on Nov. 14th before stepping with a full position for a long-term hold?
The company forecasted 44 -45 M for 2018. What if they miss?
Keep up the great work!
Judging how emotional this market is, would you suggest in waiting for Savaria's earnings on Nov. 14th before stepping with a full position for a long-term hold?
The company forecasted 44 -45 M for 2018. What if they miss?
Keep up the great work!
Q: I only have GUD in the health care space. I am thinking of adding ZUH. Is there another ETF you might recommend that is unhedged? What is your view on this sector at this time?
Q: In the 5i GROWTH portfolio which holding is likely to do best in a recession? Thanks Ron
Q: Hi,
I would like to get your opinion on the following healthcare and industrial stocks I am planning to buy in equal amounts. Would you recommend any other stocks for long term investments under my registered accounts.
Healthcare:- ABBV, MDT,PFE,GILD
Industrials:- HON,ITW, UTX
CELG is at a better value currently. Would you buy that instead of ABBV ?
Appreciate your service.
Thanks
Ninad
I would like to get your opinion on the following healthcare and industrial stocks I am planning to buy in equal amounts. Would you recommend any other stocks for long term investments under my registered accounts.
Healthcare:- ABBV, MDT,PFE,GILD
Industrials:- HON,ITW, UTX
CELG is at a better value currently. Would you buy that instead of ABBV ?
Appreciate your service.
Thanks
Ninad
Q: I have noted your critical comments from time to time about PLI management. We who have held this stock patiently for years and years share your frustration. But I think those who study the amazing product they are trying to licence realize it could well be a game changer for the sick people yearning for a cure. Anyone who buys into the drug field knows the process is long and tedious but if successful the prize is huge. So I am not sure it is fair to blame management for the delays; I think the system is what it is and we who believe in the product must sit and wait. I would appreciate your thoughts on my observations.
Thank you, Peter
Thank you, Peter
Q: I own OHI (2% weighting) in my RRSP and over the past year have seen a decent run up in the stock. The dividend is now 8%. Can I get your thoughts on the company, short position and if you feel a move out of OHI to either BIIB or PFE would be advisable. Or just add a 2% position in these other two companies? 15+ year investment horizon.
D
D
Q: Looking at adding Zoetis ( ZTS ) to my RRSP account mainly for it's growth and US exposure - have held it's former parent company Pfizer for many years. Your opinion please - seems to have been on quite a run since the spinoff.
Q: What is your take on PLI. Are the fundamentals basically OK and is it worth holding onto in the hopes of a recovery in the next year??
Q: Could I have your analysis of results today Did they meet expectations
and what do you think of guidance. Growth appears to be on track?
and what do you think of guidance. Growth appears to be on track?
Q: It's been a few months since anyone has asked about BEAT. It's been on a tear all year and apparently just announced some good results and/or guidance.
Can you summarise the recent results please and would you be a buyer?
Can you summarise the recent results please and would you be a buyer?
Q: Peter could you please give me your opinion on this small company that has come up with a test to diagnosis early stage dementia. Sounds very interesting. Is it to early to put some money to work?
Thank you!
Thank you!
Q: How old is the legal issues affect the stock?
Q: Vascepa is already fda approved and they have 200 million in sales where is the risk or is this just a partial approval from the fda pending further study and on a scale of 1 to 10 how risky is it ten being the riskiest. dave
Q: GUD reports earnings on Nov. 8, and it makes up 3% of my portfolio. Is now is a good time to add to GUD, to bring it closer to 5%? I plan on holding for at least a year.
Thank you
Grant
Thank you
Grant
Q: Morning guys:
Could u please provide your professional opinion on there recent results.
Thanks
Mark
Could u please provide your professional opinion on there recent results.
Thanks
Mark
Q: Good morning folks. With some "fun money"..perhaps half a percent...would a swing trade within my TFSA be a good bet? Now or after next weeks report? Much thanks
Q: Hi !
Early in his WEBINAR presentation last week, Peter referred to a drug co, which sounded like "emera", at about 4.$
Can you tell me what it is ?
Many thanks,
JD
Early in his WEBINAR presentation last week, Peter referred to a drug co, which sounded like "emera", at about 4.$
Can you tell me what it is ?
Many thanks,
JD
Q: what did you thing of their Q4 report that they gave yesterday.